Donald Trump Makes a $100M Promise to Kentucky 'If the Republicans Win' Midterm Elections

President Donald Trump has promised a $100 million (approximately £75 million) pharmaceutical investment in Winchester, Kentucky, for Antheia if Republicans win the November midterm elections. Speaking at Truist Arena in Highland Heights on Saturday, 17 October 2026, Trump said the Department of War would invest in the project. However, details about the proposed funding, its timing and the facility's intended operations remain unclear.

The announcement came during Trump's campaign push for Republican candidates ahead of the 3 November elections. His wording appeared to link the investment to the election outcome, although the supplied information does not establish whether the funding has been formally approved or what conditions would govern it.

Trump Ties $100M Pledge To GOP Victory

Addressing supporters at Northern Kentucky University's Truist Arena, Trump presented the proposed investment as part of his broader emphasis on American manufacturing. He described the Winchester site as a 'gigantic drug manufacturing facility', but did not explain its current status or specify what production would take place there.

'If the Republicans win, the Department of War will be investing $100 million (approximately £75 million) in the pharmaceutical company Antheia to revitalize [a] gigantic drug manufacturing facility in Winchester, Kentucky,' Trump said. 'That's a big one.'

The announcement leaves several practical questions unanswered. Trump did not explain when the investment would be made, how it would be structured or whether an agreement for the Winchester project already existed. The proposed $100 million (approximately £75 million) commitment should therefore be distinguished from funding that has already been awarded.

Antheia, a California-based pharmaceutical ingredient manufacturer, uses biosynthesis technology to produce compounds used in medicines. The company says its approach offers an alternative to supply chains that depend on agricultural sources, which can be vulnerable to poor yields and other disruptions.

The proposed Kentucky project could expand domestic pharmaceutical manufacturing, although the available information does not establish which ingredients would be produced at the Winchester facility.

Antheia's Existing Federal Backing

Antheia has previously received federal support for expanding domestic production of pharmaceutical ingredients. In March 2026, the Department of Health and Human Services' Administration for Strategic Preparedness and Response announced a $9 million (approximately £6.8 million) award to help increase US production of thebaine.

The ingredient is used to manufacture medicines for pain management, alcohol use disorder and opioid overdose reversal. Antheia announced its first commercial delivery of thebaine in 2024 and has also been developing oripavine and scopolamine.

The company had previously received another government-backed project agreement valued at up to $12 million (approximately £9 million) through a programme funded under Title III of the Defense Production Act by the Department of Health and Human Services.

Trump's proposed $100 million (approximately £75 million) investment would exceed either of those earlier commitments individually. However, the supplied details do not establish whether the Winchester proposal would expand existing projects or finance a separate operation.

The earlier awards reflect federal efforts to strengthen domestic production of critical pharmaceutical ingredients. The Health and Human Services agency cited reliance on foreign supply chains as a potential vulnerability when announcing its support for thebaine production.

Whether the new pledge will translate into an approved Winchester project remains uncertain.

Rally Remarks Range From Iran to Venezuela

Trump also addressed the conflict with Iran during Saturday's rally, predicting that it would end quickly. Describing American military action, he called it an 'excursion'.

'When I did the little excursion to the beautiful Islamic Republic of Iran, we beat the s*** out of 'em,' Trump said.

The speech was briefly interrupted when security removed a protester. Trump claimed demonstrators were paid $250 (approximately £188), but the supplied account does not establish whether the individual had received any money.

Trump initially questioned whether charges should be pursued. 'We shouldn't ruin his life and press charges, right? Just let him go,' he said, before responding to objections from the crowd with, 'Oh, no? Let's think about it.'

Later, Trump asked whether another person in the arena was a 'friend or foe'. He added that being a foe in the venue could be 'very dangerous'.

He also discussed Venezuela, claiming that the United States was taking 'Hundreds of billions of dollars' out of the country. The supplied material provides no supporting details for that figure.

Kentucky Races in Spotlight as Trump Visits

Trump's visit also highlighted competitive elections across Kentucky. Republican Senator Mitch McConnell is not seeking another term, leaving an open Senate seat contested by Republican Andy Barr and Democrat Charles Booker.

A Global Strategy Group poll released by Booker's campaign found Barr leading Booker 49 per cent to 40 per cent. Conducted from 24 to 27 August among 600 likely voters, the survey had a margin of error of plus or minus four percentage points.

Barr is also vacating Kentucky's Sixth Congressional District to pursue the Senate seat. Republican Ralph Alvarado faces Democrat Zach Dembo in that race.

A Change Research poll conducted online from 29 September to 5 October for Kentuckians Not Corruption found Dembo leading Alvarado 47 per cent to 38 per cent, with 8 per cent undecided. It surveyed 524 likely voters and had a margin of error of plus or minus 4.4 percentage points.

In the Fourth Congressional District, where Trump held his rally, Republican Ed Gallrein faces Democrat Melissa Strange. Gallrein defeated incumbent Republican Thomas Massie in the primary after receiving Trump's endorsement. The supplied information did not include recent public polling for their general-election contest.